Similar articles

• CSHP statement on pharmaceutical care. Canadian Society of Hospital Pharmacists.

  [No authors listed] [No authors listed] Can J Hosp Pharm. 1992 Dec;45(6):256-7. Can J Hosp Pharm. 1992. PMID: 10123537 No abstract available.
• Professional organizations and healthcare industry support: ethical conflict?

  Hazlet TK, Sullivan SD. Hazlet TK, et al. Camb Q Healthc Ethics. 1994 Spring;3(2):236-44; discussion 244-56. doi: 10.1017/s0963180100004977. Camb Q Healthc Ethics. 1994. PMID: 8049771 No abstract available.
• Pharmaceutical care: a survey of Canadian hospitals. Pharmaceutical Care Advisory Committee, Canadian Society of Hospital Pharmacists.

  [No authors listed] [No authors listed] Can J Hosp Pharm. 1995 Dec;48(6):352-4. Can J Hosp Pharm. 1995. PMID: 10153868 No abstract available.
• Drug detailing in the hospital: background for policy development.

  Chan J, Einarson T. Chan J, et al. Can J Hosp Pharm. 1991 Jun;44(3):161-6. Can J Hosp Pharm. 1991. PMID: 10112744 Review. No abstract available.
• Review of Canadian pharmacist involvement in adverse drug reaction reporting.

  Taras-Zasowski KM, Einarson TR. Taras-Zasowski KM, et al. Can J Hosp Pharm. 1989 Jun;42(3):105-8, 133. Can J Hosp Pharm. 1989. PMID: 10318271 Review.